REGENCELL BIOSCIENCE HOLDING (RGC) Stock Income Statement
NASDAQ:RGC • KYG7487R1002
Current stock price
28.95 USD
-0.1 (-0.34%)
At close:
28.7 USD
-0.25 (-0.86%)
After Hours:
| 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 0.00 | 61.40K | 190.00K | 150.00K | N/A | |||
| Operating Expenses | 3.77M | 4.74M | 6.27M | 7.62M | 1.38M | |||
| Research and Development | 948.30K | 1.07M | 1.58M | 2.51M | 440.00K | |||
| Selling, General, and Administrative Expenses | 2.82M | 3.67M | 4.69M | 5.11M | 940.00K | |||
| Operating Income | -3.77M | -4.74M | -6.27M | -7.62M | -1.38M | |||
| Other Income/Expense | 185.80K | 373.50K | 210.00K | 20.00K | 30.00K | |||
| Income Before Taxes | -3.58M | -4.36M | -6.06M | -7.59M | -1.35M | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Net Income | -3.58M | -4.30M | -5.87M | -7.45M | -1.35M | |||
| EBITDA | -3.69M | -4.43M | -5.98M | -7.47M | -1.35M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | |||
| Statistics | ||||||||
All data in USD